These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38703468)

  • 1. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
    Munasinghe LL; Yin W; Nathani H; Toy J; Sereda P; Barrios R; Montaner JSG; Lima VD
    Soc Sci Med; 2024 Jun; 350():116920. PubMed ID: 38703468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.
    Puyat JH; Wilton J; Fowokan A; Janjua NZ; Wong J; Grennan T; Chambers C; Kroch A; Costiniuk CT; Cooper CL; Lauscher D; Strong M; Burchell AN; Anis A; Samji H;
    J Int AIDS Soc; 2023 Oct; 26(10):e26178. PubMed ID: 37885156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England.
    Ottaway Z; Campbell L; Fox J; Burns F; Hamzah L; Kegg S; Rosenvinge M; Schoeman S; Price D; Jones R; Miller RF; Tariq S; Post FA
    HIV Med; 2024 Jul; 25(7):885-892. PubMed ID: 38529684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy.
    Izzo I; Carriero C; Gardini G; Fumarola B; Chiari E; Castelli F; Quiros-Roldan E
    AIDS Res Ther; 2021 Jun; 18(1):31. PubMed ID: 34088307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluation.
    Lima VD; Zhu J; Barrios R; Toy J; Joy JB; Williams BG; Granich R; Wu Z; Wong J; Montaner JSG
    Lancet HIV; 2024 Jul; 11(7):e461-e469. PubMed ID: 38848736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving into an urban drug scene among people who use drugs in Vancouver, Canada: Latent class growth analysis.
    Hayashi K; Ti L; Dong H; Bingham B; Day A; Joe R; Barrios R; DeBeck K; Milloy MJ; Kerr T
    PLoS One; 2019; 14(11):e0224993. PubMed ID: 31725737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada.
    Bever A; Salters K; Tam C; Moore DM; Sereda P; Wang L; Wesseling T; Grieve S; Bingham B; Barrios R
    BMJ Open; 2020 May; 10(5):e033649. PubMed ID: 32404387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.
    Duncan MC; Omondi FH; Kinloch NN; Lapointe HR; Speckmaier S; Moran-Garcia N; Lawson T; DeMarco ML; Simons J; Holmes DT; Lowe CF; Bacani N; Sereda P; Barrios R; Harris M; Romney MG; Montaner JSG; Brumme CJ; Brockman MA; Brumme ZL
    AIDS; 2024 Jul; 38(8):1120-1130. PubMed ID: 38224350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design.
    Fowokan A; Samji H; Puyat JH; Janjua NZ; Wilton J; Wong J; Grennan T; Chambers C; Kroch A; Costiniuk CT; Cooper CL; Burchell AN; Anis A;
    Int J Infect Dis; 2023 Feb; 127():162-170. PubMed ID: 36462571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.
    Lima VD; St-Jean M; Rozada I; Shoveller JA; Nosyk B; Hogg RS; Sereda P; Barrios R; Montaner JSG
    J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29130644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Outcomes and Risk Factors Among People Living with HIV.
    Spinelli MA; Jones BLH; Gandhi M
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):425-432. PubMed ID: 35930187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study.
    Morrow RL; Binka M; Li J; Irvine M; Bartlett SR; Wong S; Jeong D; Makuza JD; Wong J; Yu A; Krajden M; Janjua NZ
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.
    Ma H; Villalobos CF; St-Jean M; Eyawo O; Lavergne MR; Ti L; Hull MW; Yip B; Wu L; Hogg RS; Barrios R; Shoveller JA; Montaner JSG; Lima VD
    BMC Health Serv Res; 2018 May; 18(1):319. PubMed ID: 29720155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.
    Tattersall T; Tam C; Moore D; Wesseling T; Grieve S; Wang L; Bacani N; Montaner JSG; Hogg RS; Barrios R; Salters K
    BMC Public Health; 2022 May; 22(1):1022. PubMed ID: 35597938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk indicators for oral ulcers among people living with HIV during the first wave of the pandemic: a cross sectional study.
    Folayan MO; Zuñiga RAA; Virtanen JI; Aly NM; Ezechi OC; Lusher J; El Tantawi M; Nguyen AL
    BMC Oral Health; 2023 Aug; 23(1):600. PubMed ID: 37635219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study.
    Lima VD; Goldberg N; Lourenço L; Chau W; Hogg RS; Guillemi S; Barrios R; Montaner JS
    BMC Health Serv Res; 2015 Sep; 15():376. PubMed ID: 26369664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It's all about connection: Determinants of social support and the influence on HIV treatment interruptions among people living with HIV in British Columbia, Canada.
    Tam C; Wesseling T; Wang L; Salters K; Moore DM; Dawydiuk N; Zhu J; Grieve S; Bingham B; McLinden T; Hogg R; Barrios R
    BMC Public Health; 2023 Dec; 23(1):2524. PubMed ID: 38104090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada.
    Kaida A; Brotto LA; Murray MCM; Côté HCF; Albert AY; Nicholson V; Gormley R; Gordon S; Booth A; Smith LW; Baaske A; Galea LAM; Sadarangani M; Ogilvie GS
    AIDS Behav; 2022 Jul; 26(7):2242-2255. PubMed ID: 35020094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.